Japanese scientists have proposed a cholestenone therapy for H. pylori infection

A biotech company is rapidly developing its leading candidate – the inhaled drug GH001

Bausch Health Companies NOV03 has successfully completed the first part of the Phase 3 study.

In Tokyo, scientists have designed a new treatment for Alzheimer's disease.

Scientists believe that low total lipid levels and, in particular, HDL cholesterol in the period of acute coronavirus infection may be a prognostic marker of a severe course of the disease.

Gilead has received approval to use Trodelvy conjugate in patients with metastatic urothelial cancer.

Scientists have discovered that antibiotic-resistant pathogens and bacteria can be found in the wastewater treatment plant.

Scientists have found that selenium can reduce the risk of obesity and improve metabolism as well.

After four trials over the past two years, scientists have found a link between atrial fibrillation and taking omega-3 fatty acids.

Based on the results of a three-year study, we can hope that people who live with Fabry disease will have a chance to be cured in the nearest future.